Literature DB >> 24535583

Urological complications of illicit drug use.

Sean C Skeldon1, S Larry Goldenberg1.   

Abstract

Illicit drug use is prevalent worldwide; over 24 million people are estimated to have used recreational drugs during the past month in the UK and USA alone. Illicit drug use can result in a wide spectrum of potential medical complications that include many urological manifestations. To ensure optimal care and treatment, urologists need to be cognizant of these complications in their patients, particularly among youths. Ketamine uropathy is thought to affect over one-quarter of ketamine users and can lead to severe lower urinary tract symptoms, as well as upper tract obstruction. Cannabis use has been associated with an increased risk of bladder cancer, prostate cancer and nonseminomatous germ cell tumours in case-control studies. Fournier's gangrene has been reported following injection of heroin and cocaine into the penis. Excessive use of cough medicines can lead to the development of radiolucent stones composed of ephedrine, pseudoephedrine and guaifenesin. As the current evidence is mostly limited to case reports and case series, future epidemiological studies are needed to fully address this issue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535583     DOI: 10.1038/nrurol.2014.22

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  141 in total

1.  Pseudoephedrine urolithiasis associated with acute renal failure.

Authors:  Charles L Smith; Sheila K Gemar; Matthew J Lewis
Journal:  Nephrol Dial Transplant       Date:  2004-01       Impact factor: 5.992

2.  Comparison between imipramine and imipramine combined with pseudoephedrine in 5-12-year-old children with uncomplicated enuresis: a double-blind clinical trial.

Authors:  Mehdi Abedin Zadeh; Mohammad Kazem Moslemi; Golrasteh Kholaseh Zadeh
Journal:  J Pediatr Urol       Date:  2010-04-15       Impact factor: 1.830

3.  Methamphetamine use and risk for HIV among young men who have sex with men in 8 US cities.

Authors:  Peter Freeman; Bendu C Walker; D Robert Harris; Robert Garofalo; Nancy Willard; Jonathan M Ellen
Journal:  Arch Pediatr Adolesc Med       Date:  2011-08

Review 4.  Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).

Authors:  Aniruddh V Deshpande; Patrina H Y Caldwell; Premala Sureshkumar
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 5.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

6.  Cocaine associated priapism.

Authors:  A L Altman; A D Seftel; S L Brown; N Hampel
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

7.  Duloxetine treatment of long-term ketamine abuse-related lower urinary tract symptoms: a case report.

Authors:  Jia-Yu Chao; Hwa-An Shai
Journal:  Gen Hosp Psychiatry       Date:  2010-08-11       Impact factor: 3.238

Review 8.  Ketamine-induced vesicopathy: a literature review.

Authors:  S Middela; I Pearce
Journal:  Int J Clin Pract       Date:  2011-01       Impact factor: 2.503

9.  Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.

Authors:  R B C Kavia; D De Ridder; C S Constantinescu; C G Stott; C J Fowler
Journal:  Mult Scler       Date:  2010-09-09       Impact factor: 6.312

10.  Pseudoephedrine and guaifenesin urolithiasis: widening the differential diagnosis of radiolucent calculi on abdominal radiograph.

Authors:  G Y Song; M E Lockhart; J K Smith; J R Burns; P J Kenney
Journal:  Abdom Imaging       Date:  2005-03-04
View more
  7 in total

Review 1.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

2.  Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011.

Authors:  Russell C Callaghan; Peter Allebeck; Olof Akre; Katherine A McGlynn; Anna Sidorchuk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11       Impact factor: 4.254

Review 3.  Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers.

Authors:  Shreyas Gandhi; Gaurav Vasisth; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2017-04-11       Impact factor: 1.862

4.  Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey.

Authors:  L Boeri; P Capogrosso; E Ventimiglia; A Serino; G La Croce; A Russo; G Castagna; R Scano; A Briganti; R Damiano; F Montorsi; A Salonia
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-09-29       Impact factor: 5.554

Review 5.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

6.  Drug use disorder and risk of incident and fatal prostate cancer among Swedish men: a nationwide epidemiological study.

Authors:  Disa Dahlman; Xinjun Li; Casey Crump; Jan Sundquist; Kristina Sundquist
Journal:  Cancer Causes Control       Date:  2021-11-07       Impact factor: 2.506

Review 7.  Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis.

Authors:  J Gurney; C Shaw; J Stanley; V Signal; D Sarfati
Journal:  BMC Cancer       Date:  2015-11-11       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.